© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Capreomycin Sulfate stands as a potent cyclic polypeptide antibiotic, mainly drawn from the bacterium Streptomyces capreolus. This antibiotic usually comes as a white to slightly yellowish crystalline powder, displaying a molecular formula of C25H44N14O8·2H2SO4, and a molecular weight near 1425.45 g/mol. Capreomycin Sulfate features water-solubility and leaves no distinct smell, which eases handling in pharmaceutical environments. The HS Code used worldwide for its trade and classification is 2941.90, falling under “Antibiotics”. In syringe or vial, it presents as a solid, dense powder, often pressed into flakes, yet sometimes ground into pearl-shaped granules for more efficient reconstitution in medical settings.
Capreomycin Sulfate remains stable under routine room temperatures, though moisture and extreme heat can reduce its effectiveness. Most samples show a density around 0.45-0.55 g/cm³ in powder form, which lends itself to rapid dispersion in solution. When processed for clinical use, it is packed in powder or lyophilized solid format, ensuring fast solubility in sterile water. Crystallization techniques create needle-like or prismatic particles that support the direct preparation of injectable solutions. Capreomycin Sulfate does not flow freely and shows moderate clumping if exposed to humidity, so storage in tightly sealed glass or high-density polyethylene containers solves most stability concerns. Flake and pearl variations tend to be requested in raw material form by pharmaceutical manufacturers who value speed of dissolution and clean conversion into ready-to-administer injections.
Looking closer at the molecular make-up, Capreomycin Sulfate’s structure stems from unique peptide bonds that give it a broad spectrum of action. Its ring structure grants resistance against many bacterial enzymes while preserving bactericidal performance. The sulfate anion increases water compatibility, so pharmaceutical preparations dissolve fast in aqueous solutions. Each batch produced through fermentation is filtered and crystallized, producing material that fits clear chemical standards. Laboratory analysis uses high-performance liquid chromatography to confirm Capreomycin Sulfate’s purity by measuring its molecular markers and verifying the integrity of its composite peptide frameworks.
Industry benchmarks demand Capreomycin Sulfate to meet rigorous specifications: content assays over 950 micrograms per milligram, loss on drying under 8%, and sulfate amount within defined limits. Powdered forms maintain consistently low levels of heavy metals and are checked for microbial contamination, guaranteeing patient safety. Crystal and pearl formulations deliver the same high assay with low endotoxin content, fitting needs for both clinical and research purposes. Regular documentation verifies batch-to-batch identity using infrared spectroscopy, HPLC, and titration for sulfate. Whether pressed into slabs or granulated into free-flowing solids, Capreomycin Sulfate must ship with certificates of analysis that clearly list physical properties like density, particle size, and purity.
Capreomycin Sulfate brings a specific set of safety considerations. Its powder form is hazardous if inhaled or ingested, potentially irritating eyes, skin, or respiratory system. Workers preparing solutions use gloves, masks, and good ventilation, reducing the harmful impact of accidental exposure. Spills sweep up with HEPA-filter vacuums or wet methods, not dry brooms, to limit airborne dust. Unused powder ought to be contained in cool, dry rooms, away from acids or oxidizers. Chemical safety datasheets warn against direct contact and emphasize disposal in line with hazardous medical waste protocols. In liquid solution, Capreomycin Sulfate holds no flammability but needs careful labeling and tracking to ensure the right dilution before clinical administration.
Sourced from refined Streptomyces cultures, Capreomycin Sulfate comes as a culmination of biological fermentation, solvent extraction, and careful crystallization. Raw material suppliers deliverthe product in tightly sealed pharmaceutical-grade containers, preserving its chemical integrity, and avoiding exposure to moisture. Solutions for use in injection mix powder with sterile water and buffer agents, achieving ideal pH for safe patient delivery. Strict handling processes prevent cross-contamination with other antibiotics. Research labs sometimes request Capreomycin Sulfate in high-purity forms as control substances for calibration or as reference standards in antimicrobial studies. In either case, every lot is traceable through chain-of-custody documentation that records density, solidification method, and batch origin.
From a chemical safety perspective, Capreomycin Sulfate requires respect both as a raw material and as a finished good. The powder form can be harmful through inhalation or skin contact, as it may trigger allergic reactions or mild toxicity upon repeated exposure. Liquid solutions feature lower risk, but encourage vigilance against spillage, given the risk of contamination in hospital environments. Emergency measures—a nearby eyewash station, ventilated work hoods, and up-to-date chemical spill procedures—are simple but crucial elements in facilities housing this compound. Direct disposal into drains or regular waste streams remains strictly forbidden; chemical neutralization and incineration under controlled settings prevent environmental exposure.
As the pharmaceutical sector pushes for reliable antibiotics, the structural features of Capreomycin Sulfate—ring formation plus multiple amide links—furnish a molecular resilience that delays bacterial adaptation. Raw powder, pearled granules, and lyophilized scales all answer specific industry needs across manufacturing, compounding, and laboratory work. Industry-wide tracking under the established HS code supports safe international trade and diligent quality assurance from production floor to hospital pharmacy. The cumulative focus on molecular integrity, physical property documentation, and responsible chemical stewardship serves as a reminder that the quality of a raw material like Capreomycin Sulfate doesn’t just shape patient health; it protects those who produce or work with it every day.
